James M Dunn

Title: James M Dunn - Innovator in Controlled Release Formulations

Introduction

James M Dunn is a notable inventor based in Shreveport, LA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release formulations for orally-active medicaments. His innovative approach has the potential to enhance therapeutic efficacy while minimizing side effects.

Latest Patents

James M Dunn holds a patent for "Controlled release formulations of orally-active medicaments." This patent describes an improved tablet formulation that includes an effective amount of an active therapeutic agent, especially acidic agents like aspirin. The formulation incorporates a release-controlling agent and an erosion-promoting agent in specific proportions to achieve a criticality factor of less than 450. The tablets exhibit zero-order release in vitro and closely approximate zero-order absorption in vivo. This invention allows for the administration of aspirin tablets twice a day with minimal epigastric distress, providing the desired therapeutic effect.

Career Highlights

James M Dunn is currently associated with Boots Pharmaceuticals, Inc., where he continues to work on innovative pharmaceutical solutions. His expertise in controlled release technology has positioned him as a valuable asset in the industry.

Collaborations

James collaborates with John F Lampard, contributing to advancements in pharmaceutical formulations and enhancing the effectiveness of therapeutic agents.

Conclusion

James M Dunn's work in controlled release formulations represents a significant advancement in the pharmaceutical field. His innovative approach not only improves patient outcomes but also sets a standard for future developments in medication delivery systems.